A carregar...
Percutaneous Nerve Evaluation Test Versus Staged Test Trials for Sacral Neuromodulation: Sensitivity, Specificity, and Predictive Values of Each Technique
PURPOSE: InterStim device is an U.S. Food and Drug Administration approved minimal invasive therapy for sacral neuromodulation for lower urinary tract dysfunction. Before InterStim implantation, a trial with the appropriate screening tests is required to determine patient therapy eligibility. There...
Na minha lista:
Publicado no: | Int Neurourol J |
---|---|
Main Authors: | , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Korean Continence Society
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5083824/ https://ncbi.nlm.nih.gov/pubmed/27706006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5213/inj.1630498.249 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|